News Investor Overview Markets Stock Info Share Structure Financials Analyst Coverage News Releases Media Presentations Events November 15, 2021Leading Veterinary Academic, Dr. Jane Sykes, Joins LexaGene Board of Directors November 9, 2021LexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a Biothreat Agent November 2, 2021LexaGene Receives 2021 BioTech Breakthrough Award November 1, 2021LexaGene Finalizes Design of Pneumonia Panel October 29, 2021LexaGene Completes First Stage of U.S. ARMY DEVCOM Agreement October 27, 2021LexaGene’s MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation Summit October 26, 2021LexaGene to Host Corporate Update on November 3 October 25, 2021LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing October 7, 2021LexaGene’s Largest Study Validates Accuracy of its Veterinary Test Panel October 1, 2021LexaGene Expands Brand Awareness at Key Investor Conferences September 30, 2021LexaGene Reports on Recent Veterinary Trade Shows September 18, 2021LexaGene Adopts Corporate Governance Charters and Policies 123›»
November 9, 2021LexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a Biothreat Agent
October 27, 2021LexaGene’s MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation Summit
